nodes	percent_of_prediction	percent_of_DWPC	metapath
Clarithromycin—Abnormal behaviour—Varenicline—nicotine dependence	0.0438	0.0456	CcSEcCtD
Clarithromycin—Pancreatitis acute—Varenicline—nicotine dependence	0.0353	0.0368	CcSEcCtD
Clarithromycin—Sleep disturbance—Varenicline—nicotine dependence	0.0291	0.0303	CcSEcCtD
Clarithromycin—Platelet count decreased—Varenicline—nicotine dependence	0.0274	0.0285	CcSEcCtD
Clarithromycin—Parosmia—Varenicline—nicotine dependence	0.0251	0.0262	CcSEcCtD
Clarithromycin—Cyst—Varenicline—nicotine dependence	0.0244	0.0254	CcSEcCtD
Clarithromycin—Mania—Varenicline—nicotine dependence	0.0224	0.0233	CcSEcCtD
Clarithromycin—Accidental injury—Varenicline—nicotine dependence	0.0184	0.0192	CcSEcCtD
Clarithromycin—Gastrooesophageal reflux disease—Varenicline—nicotine dependence	0.018	0.0188	CcSEcCtD
Clarithromycin—Pulmonary embolism—Varenicline—nicotine dependence	0.0163	0.017	CcSEcCtD
Clarithromycin—Abnormal dreams—Varenicline—nicotine dependence	0.0161	0.0168	CcSEcCtD
Clarithromycin—Eructation—Varenicline—nicotine dependence	0.016	0.0167	CcSEcCtD
Clarithromycin—Nightmare—Varenicline—nicotine dependence	0.0157	0.0164	CcSEcCtD
Clarithromycin—Photophobia—Varenicline—nicotine dependence	0.0153	0.0159	CcSEcCtD
Clarithromycin—Oesophagitis—Varenicline—nicotine dependence	0.0149	0.0155	CcSEcCtD
Clarithromycin—Sleep disorder—Varenicline—nicotine dependence	0.0137	0.0142	CcSEcCtD
Clarithromycin—Disorientation—Varenicline—nicotine dependence	0.0132	0.0138	CcSEcCtD
Clarithromycin—Deafness—Varenicline—nicotine dependence	0.0132	0.0138	CcSEcCtD
Clarithromycin—Injury—Varenicline—nicotine dependence	0.0129	0.0134	CcSEcCtD
Clarithromycin—Visual disturbance—Varenicline—nicotine dependence	0.0125	0.013	CcSEcCtD
Clarithromycin—Atrial fibrillation—Varenicline—nicotine dependence	0.0125	0.013	CcSEcCtD
Clarithromycin—Hypoglycaemia—Varenicline—nicotine dependence	0.0121	0.0126	CcSEcCtD
Clarithromycin—Psychotic disorder—Varenicline—nicotine dependence	0.0116	0.012	CcSEcCtD
Clarithromycin—Liver function test abnormal—Varenicline—nicotine dependence	0.0109	0.0114	CcSEcCtD
Clarithromycin—Breast disorder—Varenicline—nicotine dependence	0.0107	0.0111	CcSEcCtD
Clarithromycin—Gastritis—Varenicline—nicotine dependence	0.0105	0.0109	CcSEcCtD
Clarithromycin—Abdominal distension—Varenicline—nicotine dependence	0.0103	0.0107	CcSEcCtD
Clarithromycin—Asthma—Varenicline—nicotine dependence	0.0102	0.0107	CcSEcCtD
Clarithromycin—Infestation NOS—Varenicline—nicotine dependence	0.00912	0.0095	CcSEcCtD
Clarithromycin—Infestation—Varenicline—nicotine dependence	0.00912	0.0095	CcSEcCtD
Clarithromycin—Depression—Varenicline—nicotine dependence	0.00909	0.00947	CcSEcCtD
Clarithromycin—Stevens-Johnson syndrome—Varenicline—nicotine dependence	0.00904	0.00942	CcSEcCtD
Clarithromycin—Stomatitis—Varenicline—nicotine dependence	0.00889	0.00926	CcSEcCtD
Clarithromycin—Conjunctivitis—Varenicline—nicotine dependence	0.00886	0.00923	CcSEcCtD
Clarithromycin—Hepatobiliary disease—Varenicline—nicotine dependence	0.00862	0.00898	CcSEcCtD
Clarithromycin—Epistaxis—Varenicline—nicotine dependence	0.0086	0.00896	CcSEcCtD
Clarithromycin—Hallucination—Varenicline—nicotine dependence	0.00814	0.00848	CcSEcCtD
Clarithromycin—Urinary tract disorder—Varenicline—nicotine dependence	0.00808	0.00842	CcSEcCtD
Clarithromycin—Connective tissue disorder—Varenicline—nicotine dependence	0.00804	0.00838	CcSEcCtD
Clarithromycin—Urethral disorder—Varenicline—nicotine dependence	0.00802	0.00836	CcSEcCtD
Clarithromycin—Visual impairment—Varenicline—nicotine dependence	0.00789	0.00822	CcSEcCtD
Clarithromycin—Erythema multiforme—Varenicline—nicotine dependence	0.00774	0.00806	CcSEcCtD
Clarithromycin—Eye disorder—Varenicline—nicotine dependence	0.00765	0.00797	CcSEcCtD
Clarithromycin—Tinnitus—Varenicline—nicotine dependence	0.00763	0.00795	CcSEcCtD
Clarithromycin—Cardiac disorder—Varenicline—nicotine dependence	0.0076	0.00791	CcSEcCtD
Clarithromycin—Angiopathy—Varenicline—nicotine dependence	0.00743	0.00774	CcSEcCtD
Clarithromycin—Immune system disorder—Varenicline—nicotine dependence	0.00739	0.0077	CcSEcCtD
Clarithromycin—Mediastinal disorder—Varenicline—nicotine dependence	0.00738	0.00768	CcSEcCtD
Clarithromycin—Chills—Varenicline—nicotine dependence	0.00734	0.00765	CcSEcCtD
Clarithromycin—Mental disorder—Varenicline—nicotine dependence	0.00717	0.00747	CcSEcCtD
Clarithromycin—Malnutrition—Varenicline—nicotine dependence	0.00713	0.00742	CcSEcCtD
Clarithromycin—Flatulence—Varenicline—nicotine dependence	0.00702	0.00731	CcSEcCtD
Clarithromycin—Dysgeusia—Varenicline—nicotine dependence	0.00698	0.00727	CcSEcCtD
Clarithromycin—Back pain—Varenicline—nicotine dependence	0.00689	0.00718	CcSEcCtD
Clarithromycin—Muscle spasms—Varenicline—nicotine dependence	0.00685	0.00714	CcSEcCtD
Clarithromycin—Tremor—Varenicline—nicotine dependence	0.00668	0.00695	CcSEcCtD
Clarithromycin—Ill-defined disorder—Varenicline—nicotine dependence	0.00661	0.00689	CcSEcCtD
Clarithromycin—Anaemia—Varenicline—nicotine dependence	0.00659	0.00686	CcSEcCtD
Clarithromycin—Agitation—Varenicline—nicotine dependence	0.00655	0.00682	CcSEcCtD
Clarithromycin—Angioedema—Varenicline—nicotine dependence	0.00651	0.00678	CcSEcCtD
Clarithromycin—Malaise—Varenicline—nicotine dependence	0.00643	0.00669	CcSEcCtD
Clarithromycin—Vertigo—Varenicline—nicotine dependence	0.0064	0.00667	CcSEcCtD
Clarithromycin—Palpitations—Varenicline—nicotine dependence	0.0063	0.00656	CcSEcCtD
Clarithromycin—Loss of consciousness—Varenicline—nicotine dependence	0.00626	0.00652	CcSEcCtD
Clarithromycin—Cough—Varenicline—nicotine dependence	0.00622	0.00648	CcSEcCtD
Clarithromycin—Convulsion—Varenicline—nicotine dependence	0.00617	0.00643	CcSEcCtD
Clarithromycin—Myalgia—Varenicline—nicotine dependence	0.00607	0.00632	CcSEcCtD
Clarithromycin—Chest pain—Varenicline—nicotine dependence	0.00607	0.00632	CcSEcCtD
Clarithromycin—Anxiety—Varenicline—nicotine dependence	0.00605	0.0063	CcSEcCtD
Clarithromycin—Unspecified disorder of skin and subcutaneous tissue—Varenicline—nicotine dependence	0.00602	0.00628	CcSEcCtD
Clarithromycin—Discomfort—Varenicline—nicotine dependence	0.00599	0.00624	CcSEcCtD
Clarithromycin—Dry mouth—Varenicline—nicotine dependence	0.00593	0.00618	CcSEcCtD
Clarithromycin—Infection—Varenicline—nicotine dependence	0.00578	0.00602	CcSEcCtD
Clarithromycin—Nervous system disorder—Varenicline—nicotine dependence	0.0057	0.00594	CcSEcCtD
Clarithromycin—Thrombocytopenia—Varenicline—nicotine dependence	0.00569	0.00593	CcSEcCtD
Clarithromycin—Skin disorder—Varenicline—nicotine dependence	0.00565	0.00588	CcSEcCtD
Clarithromycin—Hyperhidrosis—Varenicline—nicotine dependence	0.00562	0.00586	CcSEcCtD
Clarithromycin—Anorexia—Varenicline—nicotine dependence	0.00554	0.00577	CcSEcCtD
Clarithromycin—Musculoskeletal discomfort—Varenicline—nicotine dependence	0.0053	0.00552	CcSEcCtD
Clarithromycin—Insomnia—Varenicline—nicotine dependence	0.00526	0.00548	CcSEcCtD
Clarithromycin—Dyspnoea—Varenicline—nicotine dependence	0.00518	0.0054	CcSEcCtD
Clarithromycin—Somnolence—Varenicline—nicotine dependence	0.00517	0.00538	CcSEcCtD
Clarithromycin—Dyspepsia—Varenicline—nicotine dependence	0.00512	0.00533	CcSEcCtD
Clarithromycin—Decreased appetite—Varenicline—nicotine dependence	0.00506	0.00527	CcSEcCtD
Clarithromycin—Gastrointestinal disorder—Varenicline—nicotine dependence	0.00502	0.00523	CcSEcCtD
Clarithromycin—Fatigue—Varenicline—nicotine dependence	0.00501	0.00522	CcSEcCtD
Clarithromycin—Pain—Varenicline—nicotine dependence	0.00497	0.00518	CcSEcCtD
Clarithromycin—Constipation—Varenicline—nicotine dependence	0.00497	0.00518	CcSEcCtD
Clarithromycin—Feeling abnormal—Varenicline—nicotine dependence	0.00479	0.00499	CcSEcCtD
Clarithromycin—Gastrointestinal pain—Varenicline—nicotine dependence	0.00476	0.00495	CcSEcCtD
Clarithromycin—Urticaria—Varenicline—nicotine dependence	0.00462	0.00481	CcSEcCtD
Clarithromycin—Abdominal pain—Varenicline—nicotine dependence	0.0046	0.00479	CcSEcCtD
Clarithromycin—Body temperature increased—Varenicline—nicotine dependence	0.0046	0.00479	CcSEcCtD
Clarithromycin—Hypersensitivity—Varenicline—nicotine dependence	0.00428	0.00446	CcSEcCtD
Clarithromycin—CYP3A7—Xenobiotics—CYP2A7—nicotine dependence	0.00423	0.106	CbGpPWpGaD
Clarithromycin—Asthenia—Varenicline—nicotine dependence	0.00417	0.00435	CcSEcCtD
Clarithromycin—Pruritus—Varenicline—nicotine dependence	0.00411	0.00429	CcSEcCtD
Clarithromycin—Diarrhoea—Varenicline—nicotine dependence	0.00398	0.00414	CcSEcCtD
Clarithromycin—Dizziness—Varenicline—nicotine dependence	0.00385	0.00401	CcSEcCtD
Clarithromycin—CYP2C19—CYP2E1 reactions—CYP2A7—nicotine dependence	0.00382	0.0957	CbGpPWpGaD
Clarithromycin—Vomiting—Varenicline—nicotine dependence	0.0037	0.00385	CcSEcCtD
Clarithromycin—Rash—Varenicline—nicotine dependence	0.00367	0.00382	CcSEcCtD
Clarithromycin—Dermatitis—Varenicline—nicotine dependence	0.00366	0.00382	CcSEcCtD
Clarithromycin—Headache—Varenicline—nicotine dependence	0.00364	0.00379	CcSEcCtD
Clarithromycin—Nausea—Varenicline—nicotine dependence	0.00345	0.0036	CcSEcCtD
Clarithromycin—CYP3A5—Xenobiotics—CYP2A7—nicotine dependence	0.00306	0.0767	CbGpPWpGaD
Clarithromycin—CYP2C19—Xenobiotics—CYP2A7—nicotine dependence	0.00237	0.0593	CbGpPWpGaD
Clarithromycin—CYP1A2—Xenobiotics—CYP2A7—nicotine dependence	0.00184	0.0462	CbGpPWpGaD
Clarithromycin—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00176	0.0441	CbGpPWpGaD
Clarithromycin—CYP3A7—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00173	0.0435	CbGpPWpGaD
Clarithromycin—CYP3A7—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00142	0.0357	CbGpPWpGaD
Clarithromycin—CYP3A4—Xenobiotics—CYP2A7—nicotine dependence	0.00142	0.0357	CbGpPWpGaD
Clarithromycin—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00127	0.0319	CbGpPWpGaD
Clarithromycin—CYP3A5—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00125	0.0314	CbGpPWpGaD
Clarithromycin—CYP3A5—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00103	0.0258	CbGpPWpGaD
Clarithromycin—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.000982	0.0246	CbGpPWpGaD
Clarithromycin—CYP2C19—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.000969	0.0243	CbGpPWpGaD
Clarithromycin—CYP3A7—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000803	0.0201	CbGpPWpGaD
Clarithromycin—CYP2C19—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.000796	0.02	CbGpPWpGaD
Clarithromycin—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.000765	0.0192	CbGpPWpGaD
Clarithromycin—CYP3A7—Biological oxidations—CYP2A7—nicotine dependence	0.000757	0.019	CbGpPWpGaD
Clarithromycin—CYP1A2—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.000755	0.0189	CbGpPWpGaD
Clarithromycin—CYP3A7—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000746	0.0187	CbGpPWpGaD
Clarithromycin—CYP1A2—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00062	0.0156	CbGpPWpGaD
Clarithromycin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.000591	0.0148	CbGpPWpGaD
Clarithromycin—CYP3A4—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.000583	0.0146	CbGpPWpGaD
Clarithromycin—CYP3A5—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00058	0.0146	CbGpPWpGaD
Clarithromycin—CYP3A5—Biological oxidations—CYP2A7—nicotine dependence	0.000547	0.0137	CbGpPWpGaD
Clarithromycin—CYP3A5—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00054	0.0135	CbGpPWpGaD
Clarithromycin—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.000479	0.012	CbGpPWpGaD
Clarithromycin—SLC22A7—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000472	0.0118	CbGpPWpGaD
Clarithromycin—CYP2C19—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000449	0.0113	CbGpPWpGaD
Clarithromycin—CYP2C19—Biological oxidations—CYP2A7—nicotine dependence	0.000423	0.0106	CbGpPWpGaD
Clarithromycin—CYP2C19—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000417	0.0105	CbGpPWpGaD
Clarithromycin—CYP1A2—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00035	0.00877	CbGpPWpGaD
Clarithromycin—CYP1A2—Biological oxidations—CYP2A7—nicotine dependence	0.00033	0.00826	CbGpPWpGaD
Clarithromycin—CYP1A2—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000325	0.00815	CbGpPWpGaD
Clarithromycin—CYP3A4—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00027	0.00677	CbGpPWpGaD
Clarithromycin—CYP3A4—Biological oxidations—CYP2A7—nicotine dependence	0.000254	0.00638	CbGpPWpGaD
Clarithromycin—CYP3A4—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000251	0.00629	CbGpPWpGaD
Clarithromycin—ABCB1—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000151	0.00378	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—CYP2A7—nicotine dependence	0.000129	0.00325	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—CYP2A7—nicotine dependence	9.36e-05	0.00235	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—CYP2A7—nicotine dependence	7.23e-05	0.00181	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—CYP2A7—nicotine dependence	7.06e-05	0.00177	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—CYP2A7—nicotine dependence	5.64e-05	0.00141	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—CYP2A7—nicotine dependence	4.35e-05	0.00109	CbGpPWpGaD
